Merck nears $6bn biotech deal to boost cancer drug pipeline - Financial Times
Merck nears $6bn biotech deal to boost cancer drug pipeline Financial TimesMerck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports ReutersMerc...
Source: news.google.com
Merck nears $6bn biotech deal to boost cancer drug pipeline Financial TimesMerck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports ReutersMerck Nears Deal to Buy Terns Pharmaceuticals Bloomberg.comMerck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT (MRK:NYSE) Seeking AlphaMerck nears $6 billion all-cash deal to buy Terns Pharma, FT reports marketscreener.com